EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of TREM1 attenuates myocardial ischemia-reperfusion injury-induced cardiomyocyte pyroptosis by suppressing the activation of the NF-κB signaling pathway

Xiaohui Xu, Liang Cai, Xuan Dang, Jianbin Han, Yan Kou, Chunyan Rong, Junjie Kou iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0340382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Xiaohui Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Myocytes, Cardiac, NF-kappa B, Signal Transduction, Myocardial Reperfusion Injury. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Triggering receptor expressed on myeloid cells-1 (TREM-1) is a potent amplifier of inflammatory responses and plays a critical role in the pathogenesis of various infectious diseases. Notably, emerging evidence suggests that TREM-1 is also involved in the development and progression of cardiovascular diseases, such as atherosclerosis and atrial fibrillation. However, its role in myocardial ischemia/reperfusion (I/R) injury remains unclear. This study aimed to investigate the role of TREM-1 in myocardial I/R injury and to explore the potential underlying molecular mechanisms.

Methods

A hypoxia/reoxygenation (H/R) model was established using HL-1 cardiomyocytes subjected to 6 hours of hypoxia followed by 6 hours of reoxygenation. Pyroptosis levels were assessed by Hoechst-PI staining, lactate dehydrogenase (LDH) release assay, CCK-8 assay, and Western blot analysis. In vivo, a myocardial I/R injury model was established in C57BL/6 mice by subjecting them to 30 minutes of ischemia followed by 24 hours or 7 days of reperfusion. Evaluation was performed using TTC staining, Western blotting, echocardiography, histochemical staining, and immunohistochemistry.

Results

In this study, we found that TREM-1 expression was significantly upregulated in both in vitro and in vivo models of myocardial ischemia-reperfusion injury (MIRI). Pharmacological inhibition of TREM-1 by LR12 effectively reduced the levels of cardiomyocyte pyroptosis and suppressed activation of the NF-κB signaling pathway. In addition, LR12 treatment alleviated myocardial inflammation and fibrosis and improved left ventricular function in mice.Intervention experiments with MCC950, a specific NLRP3 inhibitor, confirmed that NLRP3 inhibition could mimic the anti-pyroptotic effect of LR12 and reduce the expression of pyroptosis-related proteins. Immunofluorescence experiments further verified that inhibition of NF-κB decreased NLRP3 expression, clarifying the association between TREM-1 downstream signals and NLRP3. Long-term follow-up experiments showed that LR12 treatment significantly reduced the area of myocardial fibrosis at 7 days after reperfusion.

Conclusion

Our findings indicate that inhibition of TREM-1 alleviates cardiomyocyte pyroptosis during MIRI by suppressing activation of the NF-κB signaling pathway. Therefore, TREM-1 may represent a promising therapeutic target for the treatment of myocardial ischemia-reperfusion injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacNF-kappa BSignal TransductionMyocardial Reperfusion InjuryTriggering Receptor Expressed on Myeloid Cells-1PyroptosisAnimalsMiceMice, Inbred C57BLMaleCell LineNLR Family, Pyrin Domain-Containing 3 Protein

Substanzen

NF-kappa BTriggering Receptor Expressed on Myeloid Cells-1TREM1 protein, mouseNLR Family, Pyrin Domain-Containing 3 Protein

Autor:innen und Institutionen

  • Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
  • The Key Laboratory of Myocardial Ischemia, Ministry of Education, Harbin Medical University, Harbin, Heilongjiang Province, China.

ORCID-Profile: Junjie Kou

Förderung

  • the National Natural Science Foundation of China

Zitieren

APA

Xu, X., Cai, L., Dang, X., Han, J., Kou, Y., Rong, C., & Kou, J. (2026). Inhibition of TREM1 attenuates myocardial ischemia-reperfusion injury-induced cardiomyocyte pyroptosis by suppressing the activation of the NF-κB signaling pathway. PLOS One. https://doi.org/10.1371/journal.pone.0340382

Vancouver

Xu X, Cai L, Dang X, Han J, Kou Y, Rong C, et al. Inhibition of TREM1 attenuates myocardial ischemia-reperfusion injury-induced cardiomyocyte pyroptosis by suppressing the activation of the NF-κB signaling pathway. PLOS One. 2026. doi:10.1371/journal.pone.0340382

BibTeX
@article{Xu2026,
  author = {Xu, Xiaohui and Cai, Liang and Dang, Xuan and Han, Jianbin and Kou, Yan and Rong, Chunyan and Kou, Junjie},
  title = {Inhibition of TREM1 attenuates myocardial ischemia-reperfusion injury-induced cardiomyocyte pyroptosis by suppressing the activation of the NF-κB signaling pathway},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0340382}
}
Kostenlos starten →